O'Malley R P, Mariano T M, Siekierka J, Mathews M B
Cell. 1986 Feb 14;44(3):391-400. doi: 10.1016/0092-8674(86)90460-5.
In the absence of VA RNAI, protein synthesis in adenovirus-infected HeLa cells fails because of defective initiation. Earlier work showed that the defect results from phosphorylation of the initiation factor elF-2 on its alpha subunit. We have identified the protein kinase responsible as the dsRNA-activated inhibitor of protein synthesis (DAI). DAI is present in uninfected state. It is activated in cells infected with the adenovirus mutant Ad5 dl331, which produces no VA RNAI, but not in cells infected with wild-type virus. Activation occurs during the late phase of infection with the mutant virus, and the activator appears to be dsRNA produced by symmetrical transcription of the viral genome. VA RNAI antagonizes the activation of DAI by dsRNA, but it cannot inhibit the activity of DAI once activated. We propose a mechanism for VA RNAI action based on its partially double-stranded nature.
在缺乏VA RNAI的情况下,腺病毒感染的HeLa细胞中的蛋白质合成因起始缺陷而失败。早期研究表明,该缺陷是由于起始因子elF-2的α亚基发生磷酸化所致。我们已确定负责的蛋白激酶为双链RNA激活的蛋白质合成抑制剂(DAI)。DAI以未感染状态存在。它在感染腺病毒突变体Ad5 dl331的细胞中被激活,该突变体不产生VA RNAI,但在感染野生型病毒的细胞中不被激活。激活发生在感染突变病毒的后期,激活剂似乎是由病毒基因组对称转录产生的双链RNA。VA RNAI可拮抗双链RNA对DAI的激活,但一旦DAI被激活,它就无法抑制其活性。我们基于VA RNAI的部分双链性质提出了一种VA RNAI作用机制。